Promethazine (Phenergan) for Nausea in PI Cases

Amar Lunagaria — Co-Founder & Chief Pharmacist, LienScripts | March 4, 2026 | 7 min read

Promethazine (Phenergan) is a first-generation antihistamine antiemetic with sedative properties prescribed to PI patients for nausea, vomiting, and sleep disruption. Learn its role in injury cases, combination with opioids, and $0 access through pharmacy liens.

Promethazine is a first-generation antihistamine with potent antiemetic, sedative, and anticholinergic properties prescribed to personal injury patients for nausea and vomiting related to opioid therapy, head injury, vestibular disruption, and medication-related GI disturbance. Marketed under the brand name Phenergan, promethazine acts on histamine H1, muscarinic, and dopamine receptors to suppress the vomiting reflex while providing sedation that can be therapeutically beneficial for patients with concurrent sleep disruption.

• Promethazine (Phenergan) is an antihistamine antiemetic with sedative properties that addresses both nausea and insomnia in PI patients
• It is commonly co-prescribed with opioid pain medications, and the combination product promethazine-codeine syrup treats both cough and nausea in chest injury cases
• Promethazine's sedative effect is clinically useful for PI patients with trauma-related insomnia but requires monitoring for excessive drowsiness
• LienScripts provides $0 upfront access to promethazine through pharmacy lien coverage, with all dispensing documented in the MERIT (Medication Evaluation & Rationale for Injury Treatment) report
• Promethazine prescriptions alongside opioids document the cascade of medication-related side effects flowing from the original injury

How Promethazine Works

Promethazine exerts its antiemetic effect through multiple receptor interactions:

H1 histamine antagonism: The primary mechanism. Promethazine blocks histamine H1 receptors in the vomiting center of the medulla and in the vestibular nucleus, reducing nausea triggered by motion, vestibular disruption, and histamine-mediated emetic pathways. This mechanism also produces the drug's sedative effect, as H1 receptors in the tuberomammillary nucleus of the hypothalamus regulate wakefulness.

Anticholinergic (muscarinic) blockade: Promethazine blocks muscarinic acetylcholine receptors in the vomiting center and vestibular system, contributing to its antiemetic and anti-motion sickness effects. This mechanism is particularly relevant for PI patients with vestibular symptoms from head trauma.

Dopamine D2 antagonism: Promethazine has modest dopamine D2 blocking activity in the chemoreceptor trigger zone, adding to its broad-spectrum antiemetic profile.

The combination of these three mechanisms gives promethazine a broader antiemetic spectrum than ondansetron (5-HT3 only) or metoclopramide (D2 plus prokinetic), though with greater sedation.

PI-Specific Use Cases

Opioid-Induced Nausea with Sleep Disruption

The most common PI scenario for promethazine prescribing involves a patient taking opioid pain medications who develops both nausea and difficulty sleeping. Promethazine addresses both problems simultaneously -- it suppresses the opioid-induced nausea and provides sedation that facilitates sleep. For a PI patient who is nauseous, in pain, and unable to sleep, promethazine provides meaningful multi-symptom relief.

As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist explains, "Promethazine is often the antiemetic of choice for PI patients who have concurrent insomnia because its sedative properties serve a therapeutic purpose rather than being merely a side effect. When the physician prescribes promethazine at bedtime for a patient with opioid-induced nausea and trauma-related sleep disruption, they are using a single medication to address two distinct post-injury symptoms."

Vestibular Nausea After Head Injury

Patients with concussion, TBI, or inner ear injury from trauma frequently develop vertigo and motion sickness from vestibular disruption. Promethazine's combined antihistaminic and anticholinergic activity at the vestibular nucleus makes it effective for this type of nausea, which does not respond as well to 5-HT3 antagonists like ondansetron.

Promethazine-Codeine Combination for Cough and Pain

In PI cases involving chest wall injury, rib fractures, or thoracic contusions, the promethazine-codeine syrup combination provides antiemetic, antitussive, and mild analgesic effects in a single formulation. The codeine suppresses the painful cough reflex while promethazine prevents codeine-induced nausea and provides sedation for rest.

Pre-Medication Before Painful Procedures

Promethazine is sometimes prescribed before painful medical procedures -- injections, imaging, or wound care -- to prevent nausea and provide mild sedation. Each pre-procedure promethazine prescription documents a specific clinical encounter and the anticipated distress associated with it.

Typical Dosing and Duration

Standard promethazine dosing in PI cases:

• Antiemetic (oral): 12.5 mg to 25 mg every 4 to 6 hours as needed
• Antiemetic (rectal suppository): 12.5 mg to 25 mg every 4 to 6 hours, used when oral administration is not possible due to active vomiting
• Sedation/sleep: 25 mg to 50 mg at bedtime
• Promethazine-codeine syrup: 5 mL (6.25 mg promethazine / 10 mg codeine) every 4 to 6 hours
• Injectable (IM): 12.5 mg to 25 mg for acute nausea in clinical settings (IV use carries tissue injury risk and is generally avoided)
• Duration: Typically 1 to 6 weeks, corresponding to the opioid treatment phase or acute TBI recovery period

The availability of rectal suppository formulations is clinically significant -- a patient who is actively vomiting cannot take oral medication, and the suppository form ensures continued treatment access.

Side Effects Relevant to Injury Recovery

Promethazine's side effects have direct impact on PI patients:

• Sedation -- pronounced and dose-dependent; can significantly impair daytime function, driving, and rehabilitation attendance
• Dry mouth -- from anticholinergic activity, can affect comfort and oral medication absorption
• Blurred vision -- anticholinergic effect that impairs daily function
• Constipation -- additive with opioid-induced constipation, potentially requiring additional medications
• Tissue injury risk -- IV or subcutaneous promethazine can cause severe tissue necrosis; this risk documented in medical records shows the severity of conditions being treated
• Respiratory depression -- when combined with opioids and benzodiazepines, additive CNS depression requires careful monitoring

The sedation profile documents functional limitation. A PI patient who cannot drive or participate in daytime activities because of promethazine sedation has experienced a measurable quality-of-life impact traceable to the original injury.

Documentation Value for Attorneys

Promethazine prescriptions strengthen PI demand packages:

1. Multi-symptom treatment documentation -- promethazine prescribed for nausea and sleep disruption documents two distinct injury-related symptoms addressed by one medication
2. Opioid side effect cascade -- promethazine prescribed alongside opioids documents the compounding treatment burden: injury requires opioids, opioids cause nausea, nausea requires antiemetic therapy
3. Formulation-specific evidence -- suppository prescriptions document nausea severe enough to prevent oral medication intake
4. Combination product records -- promethazine-codeine prescriptions document concurrent chest/thoracic injury with both pain and nausea
5. Sedation impact -- documented driving restrictions from promethazine sedation support loss of function claims

LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every case, providing pharmacist-signed documentation for demand packages that captures promethazine dispensing alongside all concurrent injury medications.

Pharmacy Lien Coverage

Promethazine in all formulations -- tablets, suppositories, syrup, and combination products -- is covered under the LienScripts pharmacy lien program at $0 upfront cost. Pharmacy lien coverage ensures that nausea management remains accessible regardless of the patient's insurance status or financial situation during the PI case.

Related Resources

• Ondansetron (Zofran) for Nausea After TBI
• Hydrocodone for Severe Pain After an Accident
• What Is a Pharmacy Lien?